Get the Stockscreener App
5.18
2.88%
0.14
Alvotech stock is traded at $5.18, with a volume of 176.25K.
It is up +2.88% in the last 24 hours and up +4.96% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$5.04
Open:
$5.1
24h Volume:
176.25K
Relative Volume:
0.30
Market Cap:
$1.61B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-2.80
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
+4.75%
1M Performance:
+4.96%
6M Performance:
-40.26%
1Y Performance:
-60.99%
1-Day Range:
$5.10
$5.255
1-Week Range:
$4.75
$5.255
52-Week Range:
$4.32
$13.40
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.18 | 1.57B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
123.97 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.64 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Nov-04-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO) - Seeking Alpha
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Aug Fed Impact: Can Alvotech Equity Warrant be recession proofQuarterly Profit Review & AI Enhanced Trading Signals - baoquankhu1.vn
Assessing Alvotech (ALVO) Valuation After FDA Setback And Securities Investigation Concerns - simplywall.st
Rosen Law Firm Encourages Alvotech Investors to Inquire About Se - GuruFocus
Is Alvotech the Sleeper Stock of the Year or Just Overhyped Noise? - AD HOC NEWS
ETF Watch: Is Alvotech Equity Warrant stock a smart retirement pickPortfolio Performance Report & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Retail Trends: Is HLVX likely to announce a buyback2025 Momentum Check & Community Trade Idea Sharing Platform - baoquankhu1.vn
Alvotech Faces Securities Claims After 34% Stock Drop Due to Misleading Information - Intellectia AI
Published on: 2026-01-16 12:28:06 - baoquankhu1.vn
Patterns Watch: Is Alvotech Equity Warrant stock forming a triangle patternPortfolio Update Report & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Buybacks Report: Whats the fair value of Alvotech stock2025 Top Decliners & Growth Focused Entry Point Reports - baoquankhu1.vn
ALVO INVESTOR ALERT: Hagens Berman Investigates Alvotech (ALVO) for Potential Securities Fraud Following Massive FDA-Induced Stock Crash - Sahm
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - Sahm
Alvotech (ALVO) Faces Investigation After 34% Stock Drop Following FDA Complete Response Letter - Intellectia AI
Bragar Eagel & Squire, P.C. Continues Investigations into Alvotech and Beyond Meat on Behalf of Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire
Alvotech (ALVO) Valuation Check As New $100 Million Loan Supports Biosimilar Launch Plans - simplywall.st
Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma - MSN
Alvotech (ALVO) Stock Analysis: Unpacking A Potential 349.63% Upside - DirectorsTalk Interviews
Portfolio Recap: Will Alvotech stock gain from strong economyGold Moves & Safe Capital Growth Plans - moha.gov.vn
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Gauzy Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Aug Final Week: Can Alvotech Equity Warrant sustain its profitabilityAnalyst Upgrade & Real-Time Market Trend Scan - baoquankhu1.vn
Alvotech (ALVO) secures $100 million in new financing - MSN
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - Cherokee Tribune
Alvotech (NASDAQ:ALVO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Alvotech announces European launch of biosimilar to Simponi - MSN
Alvotech’s Gobivaz Biosimilar Gains UK Approval - MSN
Alvotech Faces Securities Claims Investigation After 34% Stock Drop - Intellectia AI
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Inves - GuruFocus
Alvotech and Dr. Reddy’s gets FDA nod for Biologic License Application for AVT03 - MSN
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - Eastern Progress
Alvotech (ALVO) Secures $100 Million in New Financing - Finviz
Alvotech announces CEO transition - MSN
How Alvotech Equity Warrant stock reacts to job market data2025 EndofYear Setup & Risk Managed Investment Entry Signals - ulpravda.ru
Why Alvotech (ALVO) Is Down 7.8% After CEO Transition And Costly New Loan DealAnd What's Next - simplywall.st
Is Alvotech stock dividend yield sustainableJuly 2025 Earnings & Technical Pattern Recognition Alerts - ulpravda.ru
Is Alvotech Equity Warrant stock a contrarian buyQuarterly Profit Summary & Expert Approved Trade Ideas - ulpravda.ru
Will Alvotech (Z45) stock return to pre crash levelsMarket Growth Review & Advanced Swing Trade Entry Alerts - ulpravda.ru
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Alvotech (ALVO) Stock Price History & Data - Traders Union
Is Alvotech Equity Warrant stock a dividend growth opportunityBreakout Watch & Accurate Technical Buy Alerts - ulpravda.ru
How Alvotech (Z45) stock correlates with oil marketsMarket Weekly Review & Daily Price Action Insights - ulpravda.ru
Why Alvotech stock is a must watch in 2025July 2025 Momentum & Weekly Momentum Stock Picks - ulpravda.ru
How Alvotech stock performs in weak economyTrade Risk Assessment & AI Forecast Swing Trade Picks - ulpravda.ru
Operating margin % of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Current ratio of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Free cash flow per share of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Operating expenses (excl. COGS) of Alvotech – BX:ALVOUSD - TradingView — Track All Markets
Alvotech Earnings and Revenue – BX:ALVOUSD - TradingView — Track All Markets
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):